Karoline Fechter

421 total citations
12 papers, 301 citations indexed

About

Karoline Fechter is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Karoline Fechter has authored 12 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Karoline Fechter's work include Immune Response and Inflammation (3 papers), Immune Cell Function and Interaction (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Karoline Fechter is often cited by papers focused on Immune Response and Inflammation (3 papers), Immune Cell Function and Interaction (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Karoline Fechter collaborates with scholars based in Austria, Germany and United Kingdom. Karoline Fechter's co-authors include Akaitz Dorronsoro, César Trigueros, Jon Fernández‐Rueda, Emma Jakobsson, Kerstin Richter, Volker Vallon, Nils Heyne, Mahesh C. Khosla, Hildegard Greinix and Alexander Deutsch and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Karoline Fechter

11 papers receiving 296 citations

Peers

Karoline Fechter
Rute Moura Belgium
Karoline Fechter
Citations per year, relative to Karoline Fechter Karoline Fechter (= 1×) peers Rute Moura

Countries citing papers authored by Karoline Fechter

Since Specialization
Citations

This map shows the geographic impact of Karoline Fechter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karoline Fechter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karoline Fechter more than expected).

Fields of papers citing papers by Karoline Fechter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karoline Fechter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karoline Fechter. The network helps show where Karoline Fechter may publish in the future.

Co-authorship network of co-authors of Karoline Fechter

This figure shows the co-authorship network connecting the top 25 collaborators of Karoline Fechter. A scholar is included among the top collaborators of Karoline Fechter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karoline Fechter. Karoline Fechter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kubin, Andreas, Karoline Fechter, J.T. Hartmann, et al.. (2025). Glioblastoma targeting by water-soluble hypericin derivate HHL-PVP and photodynamic tumour killing. Biomedicine & Pharmacotherapy. 186. 118041–118041.
2.
Uhl, Barbara, Katharina Prochazka, Karoline Fechter, et al.. (2022). Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas. World Journal of Gastrointestinal Oncology. 14(1). 153–162. 5 indexed citations
3.
Uhl, Barbara, Jelena Krstić, Karoline Fechter, et al.. (2021). Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions. International Journal of Molecular Sciences. 22(24). 13311–13311. 75 indexed citations
4.
Feichtinger, Julia, Barbara Uhl, Hildegard Greinix, et al.. (2019). Deregulated CXCR4-CXCL12 Signaling Impacts on the Pathogenesis of DLBCL. Blood. 134(Supplement_1). 1519–1519. 2 indexed citations
5.
Feichtinger, Julia, Barbara Uhl, Axel Wolf, et al.. (2019). The CXCR4–CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro. International Journal of Molecular Sciences. 20(19). 4740–4740. 14 indexed citations
6.
Fechter, Karoline, Julia Feichtinger, Katharina Prochazka, et al.. (2018). Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival. Scientific Reports. 8(1). 14528–14528. 4 indexed citations
7.
Deutsch, Alexander, Beate Rinner, Martin Pichler, et al.. (2017). NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes. Cancer Research. 77(9). 2375–2386. 22 indexed citations
8.
Fechter, Karoline, Akaitz Dorronsoro, Emma Jakobsson, et al.. (2017). IFNγ Regulates Activated Vδ2+ T Cells through a Feedback Mechanism Mediated by Mesenchymal Stem Cells. PLoS ONE. 12(1). e0169362–e0169362. 7 indexed citations
9.
Dorronsoro, Akaitz, et al.. (2013). Human Mesenchymal Stromal Cell-Mediated Immunoregulation: Mechanisms of Action and Clinical Applications. PubMed. 2013. 1–8. 33 indexed citations
10.
Dorronsoro, Akaitz, et al.. (2013). Identification of the NF-κB inhibitor A20 as a key regulator for human adipogenesis. Cell Death and Disease. 4(12). e972–e972. 16 indexed citations
11.
Dorronsoro, Akaitz, Emma Jakobsson, Jon Fernández‐Rueda, et al.. (2013). Human mesenchymal stromal cells modulate T‐cell responses through TNF‐α‐mediated activation of NF‐κB. European Journal of Immunology. 44(2). 480–488. 74 indexed citations
12.
Vallon, Volker, Nils Heyne, Kerstin Richter, Mahesh C. Khosla, & Karoline Fechter. (1998). [7-D-ALA]-Angiotensin 1-7 Blocks Renal Actions of Angiotensin 1-7 in the Anesthetized Rat. Journal of Cardiovascular Pharmacology. 32(1). 164–167. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026